Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19

BACKGROUND: Inhaled pulmonary vasodilators are used as adjunctive therapies for the treatment of refractory hypoxemia. Available evidence suggest they improve oxygenation in a subset of patients without changing long-term trajectory. Given the differences in respiratory failure due to COVID-19 and “...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonti, Rajiv, Pike, C. William, Cobb, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724253/
https://www.ncbi.nlm.nih.gov/pubmed/33234007
http://dx.doi.org/10.1177/0885066620976525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724253/
https://www.ncbi.nlm.nih.gov/pubmed/33234007
http://dx.doi.org/10.1177/0885066620976525

Ejemplares similares